HIVFQ Hits The Road To Bring HIV Treatment Message To Regional QLD

Health professionals around regional Queensland are being brought up to speed on new approaches to HIV treatment and prevention during the HIV Foundation Queensland (HIVFQ)’s Treatment as Prevention Roadshow.

The roadshow is aimed at a wide range of health professionals throughout regional Queensland, including non-HIV specialists, to inform them of the adoption of the latest approach to curtailing the spread of HIV, called Treatment as Prevention or “TasP.”

HIVFQ has brought international experts to Australia to join them on the roadshow and demonstrate the validity of the new approach based on the progress they’ve made in their own countries.

Dr Rolando Barrios (pictured) from the British Columbia Centre for Excellence in HIV/AIDS is one of those experts, and he said the “TasP” approach worked two ways.

“Treatment for people living with HIV treatment leads to the amount of virus in their blood becoming so small it is undetectable. When someone has an undetectable viral load, new evidence from a larger scale study shows there were no transmissions of HIV,” he said.

“But the really ground-breaking thing about TAsP is that HIV negative people at risk can also take HIV treatment (one tablet a day) and this prevents them from being infected – this is called PrEP (pre-exposure prophylaxis).”

HIVFQ chairperson Dr Darren Russell said that to end new transmissions of HIV by 2020, it must be a multi-faceted approach with support from the medical fraternity and wider community.

“Through our TasP Roadshow we hope to see health care providers asking themselves, ‘Do I know the HIV status of my patients?’ and ‘How can I best support my patients who require life-long HIV treatment?'” he said.

“With the old class of drugs, the accepted approach was to wait as long as possible before prescribing treatment as the drugs available at the time were highly toxic and in some cases caused horrible side effects, often worsening the condition of patients.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below